Psycho-Oncologie

, Volume 7, Issue 4, pp 204–209

La confusion mentale en cancérologie

Article Original / Original Article

Résumé

La confusion mentale (CM) est la complication neuropsychique la plus fréquente survenant chez les patients atteints de cancer. Signe singulier, car parfois spectaculaire, de vulnérabilité, elle est souvent associée à un taux élevé de morbidité et de mortalité et provoque une détresse importante chez les patients, leurs proches et les soignants. Pour réduire cet impact, il apparaît essentiel d’améliorer le dépistage et la précocité des démarches diagnostiques et thérapeutiques, la CM étant souvent sous-diagnostiquée et de ce fait traitée de façon inappropriée. Le traitement doit être étiologique, symptomatique et environnemental, à adapter dans les phases palliatives.

Mots clés

Confusion Complication neuropsychique Diagnostic précoce Traitement étiologique Traitement symptomatique et environnemental 

Delirium in patients with cancer

Abstract

Delirium is the most common neuropsychiatric complication seen in patients with cancer. Delirium is often a spectacular sign of vulnerability, although it is associated with significant morbidity and mortality as well as distress for patients, families and caregivers. Improved recognition and early treatment of delirium are key points in order to reduce its prevalence and negative outcomes, delirium being too often under-recognized and inappropriately treated. Treatment is an association of pharmacological and nonpharmacological interventions, to be adapted in the palliative care setting.

Keywords

Delirium Neuropsychiatric complication Early diagnostic Pharmacological treatment Nonpharmacological treatment 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Alici-Evcimen Y, Breitbart W (2008) An update on the use of anti-psychotics in the treatment of delirium. Palliat Support Care 6:177–182PubMedCrossRefGoogle Scholar
  2. 2.
    American Psychiatric Association (1999) Practice guideline for the treatment of patients with delirium. Am J Psychiatry 156(Suppl 5): 1–20Google Scholar
  3. 3.
    Bond S (2008) Delirium resolution in hospitalized older patients with cancer. Cancer Nursing 31(6):444–450PubMedCrossRefGoogle Scholar
  4. 4.
    Breitbart W, Alici Y (2008) Agitation and delirium at the end of life “We could not manage him” Jama 300(24):2898–2910PubMedCrossRefGoogle Scholar
  5. 5.
    Breitbart W, Alici Y (2012) Evidence-based treatment of delirium in patients with cancer. J Clin Oncol 30:1206–1214PubMedCrossRefGoogle Scholar
  6. 6.
    Bush SH, Bruera E (2009) The assessment and management of delirium in cancer patients. Oncologist 14:1039–1049PubMedCrossRefGoogle Scholar
  7. 7.
    Caraceni A, Nanni O, Maltoni M, et al (2000) The impact of delirium on the short-term prognosis of advanced cancer patients. Cancer 89:1145–1148PubMedCrossRefGoogle Scholar
  8. 8.
    Dyer CB, Ashton CM, Teasdale TA (1995) Postoperative delirium. A review of 80 primary data-collection studies. Arch Intern Med 155:461–465Google Scholar
  9. 9.
    Elie D, Gagnon P, Gagnon B, et al (2010) Using psychostimulants in end-of-life patients with hypoactive delirium and cognitive disorders: a literature review. Can J Psychiatry 55(6):386–393PubMedGoogle Scholar
  10. 10.
    Gagnon B, Low G, Schreier G (2005) Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study. Rev Psychiatr Neurosci 30(2):100–107Google Scholar
  11. 11.
    Gagnon P (2008) Treatment of delirium in supportive and palliative cancer. Curr Opin Support Palliat care 2(1):60–66PubMedCrossRefGoogle Scholar
  12. 12.
    Gagnon P, Allard P, Gagnon B, et al (2012) Delirium prevention in terminal cancer: assessment of a multicomponent intervention. Psychooncology 21:187–194PubMedCrossRefGoogle Scholar
  13. 13.
    Gaudreau JD, Gagnon P, Harel F (2005a) Impact on delirium detection of using a sensitive instrument integrated into medical practice. J Pain Symptom Manage 29(4):68–75CrossRefGoogle Scholar
  14. 14.
    Gaudreau JD, Gagnon P, Tremblay A (2005b) Psychoactive medication and risk of delirium in hospitalized cancer patients. J Clin Onc 23(27):6712–6718CrossRefGoogle Scholar
  15. 15.
    Hun-Kang J, Hoon Shin S, Bruera E (2013) Comprehensive approaches to managing delirium in patients with advanced cancer. Cancer Treat Rev 39:105–112CrossRefGoogle Scholar
  16. 16.
    Inouye SK, Van Dyck CH, Alessi CA, et al (1990) Clarifying confusion: the confusion assessment method-A new method for the detection of delirium. Ann Intern Med 113:941–948PubMedCrossRefGoogle Scholar
  17. 17.
    Inouye SK (1999) A multicomponent intervention to prevention. N Engl J Med 340(9):669–676PubMedCrossRefGoogle Scholar
  18. 18.
    Inouye SK (2006) Delirium in older persons. N Engl J Med 354:1157–1165PubMedCrossRefGoogle Scholar
  19. 19.
    LeGrand SB (2012) Delirium in palliative medicine: a review. J Pain Symptom Manage 44:583–594PubMedCrossRefGoogle Scholar
  20. 20.
    Leonard M, Agar M, Mason C, et al (2008) Delirium issues in palliative care settings. J Psychosom Res 65:289–298PubMedCrossRefGoogle Scholar
  21. 21.
    Liptzin B, Levkoff SE (1992) An empirical study of delirium subtypes. Br J Psychiatry 161:843–845PubMedCrossRefGoogle Scholar
  22. 22.
    Lonergan E, Britton AM, Luxemberg J, et al (2007) Antipsychotics for delirium. Cochrane Database System Rev CDOO5594Google Scholar
  23. 23.
    Meyer-Massetti M, Cheng C, Sharpe B, et al (2010) The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond? J Hosp Med 5(4):E8–E16PubMedCrossRefGoogle Scholar
  24. 24.
    Référentiels interrégionaux en Soins Oncologiques de Support (2011) Confusion mentale en cancérologie. Oncologie 13:357–372CrossRefGoogle Scholar
  25. 25.
    Reich M, Soulié O, Revnic J (2011) Quelles prises en charge de la confusion mentale en soins palliatifs? Med Palliat 10:4–13Google Scholar
  26. 26.
    Stagno D, Gibson C, Breitbart W (2004) The delirium subtypes: a review of prevalence, phenomenology, pathophysiology, and treatment response. Palliat Support Care 2:171–179PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag France 2013

Authors and Affiliations

  1. 1.Psychiatre, unité de psycho-oncologieInstitut Sainte-CatherineAvignon cedex 09France

Personalised recommendations